Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer.
about
A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatmentThe ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation.Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL.Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cellsEnhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion.New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.Differential response of normal and transformed mammary epithelial cells to combined treatment of anti-miR-21 and radiation.Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas.Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis.The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells.Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene.EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma.Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
P2860
Q28641649-527C1EFC-121D-424E-A536-F3C3C67252A6Q34221605-0A1C4711-39A7-4227-85F7-60A2D7479B1AQ34416229-6F0BF724-5550-48FD-8C4E-141DC6C4A108Q34457270-C122B0A1-D6A0-4F3A-BC8A-12BD0B2249E8Q34760541-39DBF248-B455-4471-83F1-A9B04805FCCAQ35092068-7A20548E-C197-4A46-B44C-89659B051697Q36614322-68FFE7A0-A502-4E42-9A57-93574BA57955Q36709220-397D341E-59B2-4959-8013-B4EFAD4210C5Q37323030-4D7CECB7-BE4B-4F73-A505-C91F817DFC75Q37716643-C97482EB-43A4-4E33-A2A3-DC4B43EC0C27Q38722374-010A2CD1-05D2-4B72-8176-49DCDBB50CFCQ39140897-EBE182AA-7D80-4146-9AEC-4C51655A55CBQ39406143-9CBDA4BB-F15F-4CAB-915C-43AFE9189F06Q39460016-0F5520CA-C7C1-4E2C-A155-F362E46CD0B3Q39580432-1A2C914A-357B-4929-8256-D4708FB680ECQ39762430-C216D710-E609-4D4C-9189-EB5335040592Q40694315-923087B9-2E98-4A7B-8C80-DE64A928EAE8Q41614294-320838A5-63D4-4D2C-B4EF-723539E4B38EQ43486412-43212DD2-747D-4928-BC14-CDFECFE4323CQ48328324-7EF30D79-4D4F-49A0-A7D7-723835287619Q53057022-DA50E668-F066-49FD-AEE7-69603D2EA408
P2860
Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Efficient shRNA delivery into ...... iral vector-mediated transfer.
@en
type
label
Efficient shRNA delivery into ...... iral vector-mediated transfer.
@en
prefLabel
Efficient shRNA delivery into ...... iral vector-mediated transfer.
@en
P2093
P2860
P1476
Efficient shRNA delivery into ...... iral vector-mediated transfer.
@en
P2093
Daniela Angermeier
Falko Fend
Heinz Höfler
Leticia Quintanilla-Martinez
Margit Klier
P2860
P2888
P356
10.1007/S12308-008-0020-X
P577
2008-11-19T00:00:00Z